Stock SNCA PALISADE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Palisade Bio, Inc.

Equities

SNCA

US6963894026

Real-time Estimate Cboe BZX
Other stock markets
 11:44:52 2024-04-24 am EDT 		5-day change 1st Jan Change
5.675 USD -4.14% Intraday chart for Palisade Bio, Inc. -11.36% -33.90%
Apr. 23 Palisade Bio Collaborating With Strand Life Sciences on Ulcerative Colitis Therapy MT
Apr. 23 Palisade Bio, Inc. Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach CI

Chart calendar Palisade Bio, Inc.

645a7262dd987e0b81a82ed.Vu9v99C5cV9gC2tq3H1ccxRqu2kluajGC_XwhPLLrnU.Pas4xYThKBcNfS4HjlA9Cks1714W3cO2f6qC4q24z006sDmahO45bVleCA~9a87c10f451fc45b0536ff2891bad222

Upcoming events on Palisade Bio, Inc.

2024-05-09 Q1 2024 Earnings Release (Projected)
2024-05-21 12:30 pm Digestive Disease Week Conference
2024-08-19 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-13 Q4 2024 Earnings Release (Projected)

Past events on Palisade Bio, Inc.

2024-04-08 IBD Innovate Product Development for Crohn & Colitis Conference
2024-04-07 Reverse Split: 1 of 15
2024-03-27 08:00 am Q4 2023 Earnings Release
2024-03-24 Extraordinary Shareholders Meeting
2024-01-26 10:00 pm Crohn Colitis Congress
2023-11-10 08:05 am Q3 2023 Earnings Release
2023-10-25 02:00 pm Ask the CEO Virtual Investor Conference
2023-08-11 08:05 am Q2 2023 Earnings Release
2023-06-22 11:30 am Maxim Group Virtual Healthcare Conference
2023-06-08 01:00 pm Annual General Meeting
2023-05-12 08:05 am Q1 2023 Earnings Release
2023-03-23 08:05 am Q4 2022 Earnings Release
2023-01-17 03:00 pm Virtual Investor Conference
2022-11-15 Reverse Split: 1 of 50
2022-11-14 08:45 am Q3 2022 Earnings Release
2022-10-17 04:15 pm American College of Surgeons Clinical Congress
2022-10-06 12:00 pm Extraordinary Shareholders Meeting
2022-10-04 01:00 pm Extraordinary Shareholders Meeting
2022-09-29 11:30 am Ladenburg Thalmann Healthcare Conference
2022-09-16 11:00 am LB1148 Phase 3 Study Results Call

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,25
0,25
0%
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-41,9
-41,2
-1.67%		-15,3
-15,4
0.82%		-13,1
-12,8
-2.3%
-12,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-26,6
-29,1
8.4%		-14,3
-14,1
-1.08%		-12,3
-12,2
-0.89%
-12,5

Net income
Million USD		Released
Forecast
Spread 		-26,6
-33,1
19.59%		-14,3
-14,3
0.36%		-12,3
-12,4
0.59%
-12,5

EPS
USD		Released
Forecast
Spread 		-2 145
-2 947
27.23%		-248
-321
22.87%		-27,0
-28,1
4%
-14,4

Announcement Date17/03/2222/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,25
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,03
-3,10
-29.97%		-3,89
-3,92
0.92%		-3,57
-3,35
-6.63%		-4,00
-3,72
-7.71%		-3,85
-3,77
-2.07%		-2,53
-3,66
30.94%		-3,61
-3,10
-16.36%		-3,78
-3,35
-12.84%		-3,15
-3,04
-3.7%
-3,16


-3,04


-3,10


-3,16

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		1,07
-3,11
134.48%		-4,21
-3,92
-7.16%		-2,34
-3,35
30.03%		-3,99
-3,72
-7.39%		-3,72
-3,77
1.38%		-2,34
-3,66
36.13%		-3,39
-3,10
-9.35%		-3,60
-3,35
-7.28%		-2,97
-3,04
2.38%
-3,16


-3,04


-3,10


-3,16

Net income
Million USD		Released
Forecast
Spread 		1,07
-3,11
134.48%		-4,21
-3,92
-7.16%		-2,34
-3,35
30.03%		-3,99
-3,72
-7.39%		-3,72
-3,77
1.38%		-2,34
-3,66
36.13%		-3,39
-3,10
-9.35%		-3,60
-3,35
-7.28%		-2,97
-3,04
2.38%
-3,16


-3,04


-3,10


-3,16

EPS
USD		Released
Forecast
Spread 		480
-176
372.34%		-195
-210
7.14%		-90,0
-127
29.41%		-60,0
-60,0
0%		-89,8
-36,5
-146%		-8,10
-10,9
25.52%		-7,95
-6,83
-16.48%		-7,35
-6,15
-19.51%		-3,75
-5,18
27.54%
-3,75


-3,60


-3,60


-3,45

Announcement Date17/03/2213/05/2215/08/2214/11/2222/03/2311/05/2310/08/2309/11/2326/03/24----

Upcoming sector events for Palisade Bio, Inc.

2024-04-24 PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release
2024-04-24 SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release
2024-04-24 HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release
2024-04-24 PURETECH HEALTH PLC: Q4 2023 Earnings Release
2024-04-25 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
More events

Past sector events for Palisade Bio, Inc.

Today 01:45 am ADDLIFE AB: Q1 2024 Earnings Release
Today SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release
Today MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected)
Today CUREVAC N.V.: Q4 2023 Earnings Release
Today ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release
Today EVOTEC SE: Q4 2023 Earnings Release
2024-04-22 SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release
2024-04-22 04:15 pm MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SNCA Stock
  4. Calendar Palisade Bio, Inc.